HASEGAWA, M., SATO, S., & TAKEHARA, K. (1999). Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α) and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis. Blackwell Science Inc.
Chicago Stili AlıntıHASEGAWA, M., S. SATO, ve K. TAKEHARA. Augmented Production of Chemokines (monocyte Chemotactic Protein-1 (MCP-1), Macrophage Inflammatory Protein-1α (MIP-1α) and MIP-1β) in Patients With Systemic Sclerosis: MCP-1 and MIP-1α May Be Involved in the Development of Pulmonary Fibrosis. Blackwell Science Inc, 1999.
MLA AlıntıHASEGAWA, M., S. SATO, ve K. TAKEHARA. Augmented Production of Chemokines (monocyte Chemotactic Protein-1 (MCP-1), Macrophage Inflammatory Protein-1α (MIP-1α) and MIP-1β) in Patients With Systemic Sclerosis: MCP-1 and MIP-1α May Be Involved in the Development of Pulmonary Fibrosis. Blackwell Science Inc, 1999.